On November 4, 2026, the Ministry of Food and Drug Safety (MFDS) of South Korea issued the draft revision of the Guideline for the Management of Cosmetic Labeling and Advertising; the Korea Cosmetics Association (KCIA) forwarded it to enterprises for comments on November 5. The comment period closed on November 9, 2026.
Background
By listing examples of prohibited expressions in labeling and advertising and specifying the main targets of substantiation data requirements, the guideline provides a basis for judgment for cosmetic manufacturers, responsible cosmetic sellers, sellers of customized cosmetics, and sellers. The current version is the 10th edition issued on August 14, 2025.
It should be noted that this document is a guideline compiled by Korea’s MFDS for enterprises and does not have legally binding force; expressions such as “shall””in the text are for reference only. However, the examples listed therein have become, in practice, an important basis for determining whether labeling or advertising violates Article 13 of the Cosmetics Act.
Main Revisions
Centering on supplementing examples of prohibited expressions and substantiation targets, this revision can be summarized in three aspects:
- Expanding the examples of prohibited expressions in Appendix 1 “Scope and Criteria of Expressions for Cosmetic Labeling and Advertising”, covering categories such as disease names, body improvement, medical aesthetic procedures, ingredients and human-derived ingredients, methods of use, and adult products;
- Adding sun protection factor-related labeling to Appendix 2 “Main Targets of Substantiation for Cosmetic Labeling and Advertising”;
- Adding a note on the method for labeling the content or concentration of ingredients.
Appendix 1: 4 Categories of Expansion
Appendix 1 lists prohibited expressions under item 1, item 2, and item 4 of Paragraph 1 of Article 13 of the Cosmetics Act.
1. Expansion of Prohibited Expressions Related to Disease Names
Under item 1 (relating to disease diagnosis, treatment, alleviation, handling, prevention, and medical efficacy and effects), a new column of “names of other diseases” has been added, expressly listing the following disease names as prohibited expressions:
- senile warts, condyloma acuminatum, athlete’s foot, tinea capitis, rhinitis, warts, skin tags, seborrheic scalp dermatitis, vaginitis, herpes, etc.
2. Expressions Related to Body Improvement, Medical Aesthetic Procedures, and Medical Devices
Under the “body improvement expressions” of item 1, the entry “facial contour improvement, V-line” has been expanded to “facial contour improvement, V-line, double chin improvement, and mid-face reduction””.
Under item 4 (relating to designation or official recognition by specific persons or institutions), the examples of “advertising beyond the scope of cosmetics” have been expanded as follows:
- The entry “Botox” now additionally includes “Skin Tox (Skinvive, an injectable product for skin improvement)”;
- The entry “expressions related to procedures such as laser and Carboxy” now additionally includes “Juvelook (an injectable filler product)”;
- A new entry of “expressions related to medical devices (Medical Device, MD)” has been added.
3. Ingredients, Human-derived Ingredients, and Narcotic-class Ingredients
Under item 2 (relating to functional cosmetics), the example of “ingredient-related expressions” has been expanded from “ingredient XX with anti-wrinkle effects” to “ingredient XX with anti-wrinkle effects, highly functional ingredient XX”, bringing generalized characterizations such as “highly functional” into the examples liable to cause misperception of functionality.
Under the “human-derived ingredient-related expressions” of item 4, the examples of specific ingredients liable to cause misperception have been expanded from “exosomes, liposomes, etc.” to “exosomes, liposomes, ECM, etc.”, with “ECM cosmetics, ECM” added under the examples.
A new entry has been added: for ingredients classified as narcotics under the Act on the Control of Narcotics, etc. that must not be added to cosmetics (tetrahydrocannabinol (THC), cannabidiol (CBD), etc.), expressions indicating their names or contents constitute prohibited expressions even where they are naturally present in trace amounts.
4. Expressions Related to Methods of Use and Adult Products
Under “expressions contrary to facts or liable to mislead consumers”, the entries of “topical application” and “topical vaginal lactic acid bacteria” have been added.
Appendix 2: Sun Protection Factors Newly Added as Substantiation Targets
Three items have been newly added:
- Sun protection factor (SPF);
- Water-resistant sun protection factor (SPF, water resistance, or persistent water resistance);
- Ultraviolet A protection grade (PA).
The means of substantiation are to rely on the basis already contained in the examination data of the sun-protection functional cosmetic that has undergone examination, or to separately submit substantiation data for the function (data of human application tests or in vitro tests). Appendix 2 also reiterates that substantiation targets are not limited to the items listed in the table, and that substantiation data may be requested for any labeling or advertising relating to facts.
Labeling Method: Criteria for Labeling the Content and Concentration of Ingredients
A new note has been added: when labeling or advertising the content or concentration of an ingredient, the finished product shall be used as the basis and the unit of the content or concentration shall be indicated, so as to reduce consumer misperception; when indicating units below parts per million (ppm, ppb, etc.), it is recommended to indicate the percentage (%) in parallel.
This requirement dovetails with the existing rules for labeling extract content (based on the finished product and excluding the content of extraction and dilution solvents; where the solvent ratio is difficult to confirm, “containing extraction solvent” must be indicated).
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Our Services
- South Korea Cosmetics Product Notification & Registration (General Cosmetics, Functional Cosmetics)
- South Korea Cosmetic Ingredient Database (KCID) Registration
- South Korea Responsible Party (RP) Services
- South Korea Cosmetic Formula Review
- South Korea Cosmetic Label Review
- Quality Inspection
Further Information:

